Publication | Open Access

Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma

OncologyMedicinePathologyAdvanced Gastric CarcinomaAnti-cancer AgentCancer TreatmentPharmacologyCancer Research